ArticleOncotarget2018

APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer.

Caroline K Søgaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.